MedTrace Logo

Phosphodiesterase 4 Gene Variant and Salbutamol Response in Persistent Childhood Asthma

NCT03592212 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2026-05-06

No results posted yet for this study

Summary

This study is designed to investigate whether the Phosphodiesterase 4 gene variability could be implicated in the salbutamol responsiveness in asthmatic children.

Conditions

Interventions

DRUG

Salbutamol

Measurement of bronchodilator response (BDR)

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Guillaume LEZMI, MD, PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-23
Primary Completion
2019-11-14
Completion
2019-11-14

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03592212 on ClinicalTrials.gov